Linked research, clinical, and regulatory source pathways.
Company profile
About R1 RCM
R1 RCM is a leading revenue cycle management company that has been transforming healthcare financial operations for over two decades. The company partners with 95 of the top 100 US health systems, delivering comprehensive solutions that combine deep operational expertise with cutting-edge AI technology. R1's mission is to make healthcare work better for all by addressing the complex challenges of revenue cycle management through innovation and automation. The company has introduced Phare, healthcare's first Revenue Operating System, which represents a fundamental shift in how revenue cycle operations are managed. Phare uses an agentic AI approach with orchestration agents that seamlessly route work between specialist AI agents and human experts across the entire revenue cycle. The platform is built on 20 years of decisions, actions, and outcomes data, with 280 million transactions annually informing its decision-making processes. R1 offers three core enterprise products: Phare Access for patient intake and verification, Phare Claim for automated coding and claim optimization, and Phare Flow for accelerated payment follow-up and denial management. The company provides two engagement models: Operating Partnerships for comprehensive transformation with workforce transition to R1, and Agentic Solutions for organizations wanting R1's technology while maintaining operational ownership. R1 also operates R37, its dedicated AI innovation lab, which develops and scales AI solutions aimed at achieving comprehensive automation and real-time claim adjudication. The company serves health systems, physician practices across 70+ specialties, and rural/community hospitals.
Company description R1 RCM official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
No clinical focus areas are currently listed.
Who it serves
- Community Hospitals
- Critical-Access Hospitals
- Health Systems
- Physician Practices
- Rural Hospitals
Deployment & integration
Deployment information is currently being developed.
Recorded integration context: Banking systems, EMR systems, Payer systems.
Geographic context
Company milestones
Platform expansion
Launched Phare as healthcare's first Revenue Operating System. Launched Phare Audit for AI-native reimbursement capture. Announced strategic partnership with Sierra. Transitioned to private company with significant capital allocation to R37 AI innovation lab.
Partnerships
Recorded partners
- 95 of top 100 US health systems
- Intermountain Healthcare
- Providence
- Sierra (strategic partnership for AI-driven experiences)
- Singing River Health System
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
No source-backed Company products are currently listed.
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Perioperative Care of Older Adults: Comment.Anesthesiology · Jul 1, 2025
Health care policy that relies on poor measurement is ineffective: Lessons from the hospital readmissions reduction program.Health services research · Jun 1, 2023
Improving healthcare value: Medicare reimbursement for short-stay inpatient versus outpatient medical hospitalizations.Journal of hospital medicine · Jun 1, 2022
Challenging the Myths of the Against Medical Advice Discharge.Annals of internal medicine · Mar 1, 2022
Potential Financial Effects on Hospitals of the Removal of Common Orthopaedic and Spinal Procedures From Medicare's "Inpatient-Only" List: A Comparison of the Medicare Fee-for-service Payment Model Versus Maryland's Global Budget Revenue Model.The Journal of the American Academy of Orthopaedic Surgeons · Jan 15, 2022
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Enterprise partnerships
Enterprise partnerships
Enterprise partnerships
Enterprise partnerships
Overall company performance
Overall automation achievement
Phare Access
Phare Access
Phare Access
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from R1 RCM
Recent articles published on R1 RCM's official website.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Healthcare Operations & Administration
Companies using AI to optimize hospital operations, automate administrative workflows, improve scheduling, manage healthcare resources, coordinate care delivery, or reduce operational inefficiencies. Includes prior authorization automation, credentialing, billing, care coordination, and AI tools that help health systems run more efficiently.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.